Erratum To: Genomics-Guided Precise Anti-Epileptic Drug Development

Neurochemical Research - United States
doi 10.1007/s11064-017-2396-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs

Diagnostics
Clinical Biochemistry
2019English

Targeting Anti-Epileptic Drug Therapy Without Collateral Damage: Nanocarrier-Based Drug Delivery

Epilepsy Currents
Neurology
2012English

Functional Genomics and Pharmacology for Drug Development.

Drug Metabolism and Pharmacokinetics
2001English

Anti-Epileptic Drug Loaded Niosomal Transdermal Patch for Enhanced Skin Permeation

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2019English

The Use of Genomics to Drive Kidney Disease Drug Discovery and Development

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2020English

Development and Clinical Applications of the Dried Blood Spot Method for Therapeutic Drug Monitoring of Anti‐epileptic Drugs

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Imaging Biomarkers of Anti-Epileptic Drug Action: Insights From Magnetic Resonance Imaging

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2018English

Measurement of Levetiracetam Drug Levels to Assist With Seizure Control and Monitoring of Drug Interactions With Other Anti-Epileptic Medications (AEMs)

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy